全文获取类型
收费全文 | 266篇 |
免费 | 15篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 7篇 |
妇产科学 | 10篇 |
基础医学 | 31篇 |
口腔科学 | 2篇 |
临床医学 | 45篇 |
内科学 | 60篇 |
皮肤病学 | 14篇 |
神经病学 | 25篇 |
特种医学 | 15篇 |
外科学 | 24篇 |
综合类 | 3篇 |
预防医学 | 20篇 |
眼科学 | 1篇 |
药学 | 13篇 |
肿瘤学 | 12篇 |
出版年
2024年 | 1篇 |
2023年 | 4篇 |
2022年 | 4篇 |
2021年 | 17篇 |
2020年 | 5篇 |
2019年 | 11篇 |
2018年 | 5篇 |
2017年 | 2篇 |
2016年 | 8篇 |
2015年 | 6篇 |
2014年 | 16篇 |
2013年 | 9篇 |
2012年 | 14篇 |
2011年 | 14篇 |
2010年 | 16篇 |
2009年 | 10篇 |
2008年 | 19篇 |
2007年 | 19篇 |
2006年 | 17篇 |
2005年 | 25篇 |
2004年 | 9篇 |
2003年 | 7篇 |
2002年 | 14篇 |
2000年 | 1篇 |
1999年 | 2篇 |
1998年 | 5篇 |
1996年 | 2篇 |
1995年 | 2篇 |
1993年 | 1篇 |
1992年 | 2篇 |
1991年 | 1篇 |
1987年 | 1篇 |
1985年 | 1篇 |
1984年 | 3篇 |
1983年 | 2篇 |
1982年 | 1篇 |
1979年 | 1篇 |
1978年 | 1篇 |
1976年 | 1篇 |
1972年 | 1篇 |
1934年 | 1篇 |
1933年 | 1篇 |
1923年 | 1篇 |
1920年 | 1篇 |
排序方式: 共有284条查询结果,搜索用时 15 毫秒
1.
A heterogeneous set of FMR1 proteins is widely distributed in mouse tissues and is modulated in cell culture 总被引:8,自引:7,他引:8
2.
Tone Nygaard Flølo Grethe S. Tell Ronette L. Kolotkin Anny Aasprang Tone M. Norekvål Villy Våge John R. Andersen 《Surgery for obesity and related diseases》2019,15(2):161-167
Background
A person's confidence to control eating, eating self-efficacy (ESE), has been identified as a target for long-term weight management in nonsurgical weight loss interventions, but has to a limited extent been studied after bariatric surgery.Objective
We investigated the association between ESE, weight loss, and obesity-specific quality of life (QOL) after sleeve gastrectomy (SG).Setting
A single-center longitudinal study.Methods
Data from adult patients were collected before SG, and at mean 16 months (±standard deviation 4 mo) and 55 (±4) months postoperatively. ESE was measured by the Weight Efficacy Lifestyle Questionnaire Short-Form. Multiple regression analyses were performed with excess body mass index loss (%EBMIL) and obesity-specific QOL as dependent variables. Age, sex, and other preoperative values were covariates in all models.Results
Of 114 preoperative patients, 91 (80%) and 84 (74%) were available for follow-up 16 and 55 months after SG, respectively. Mean %EBMIL from baseline to 16 and 55 months was 76% (95% confidence interval: 71.9, 79.6) and 67% (95% confidence interval: 61.9, 72.2), respectively. Preoperative ESE scores improved significantly at both 16 and 55 months (P?=?.002) but did not predict postoperative %EBMIL or QOL at 55 months (β?=??.08, P?=?.485). Greater change in ESE from 0 to 16 months predicted higher %EBMIL (β?=?.34, P?=?.013) at 55 months, and improvements in ESE from 0 to 55 months were significantly associated with higher %EBMIL (β?=?.46, P?=?.001) and obesity-specific QOL (β?=?.50, P < .001) 55 months after SG.Conclusion
Significant improvements in ESE were seen at 16 months, and remained high at 55 months after SG in this cohort. Patients who improved their ESE the most also experienced the highest weight loss and obesity-specific QOL 5 years postoperatively. Future research should address whether enhancement of ESE corresponds to sustained improvements in eating behavior after bariatric surgery. 相似文献3.
4.
Viskoper R Shapira I Priluck R Mindlin R Chornia L Laszt A Dicker D Gavish B Alter A 《American journal of hypertension》2003,16(6):484-487
BACKGROUND: Recent studies have demonstrated the antihypertensive effect of slow breathing exercises, guided interactively by a device, in patients with uncontrolled blood pressure (BP) without changing medication. This study examined the response to the same treatment protocol in resistant hypertensives. METHODS: Seventeen resistant hypertensives exercised device-guided slow breathing for 8 weeks, 15 min daily, and self-monitored BP. Data stored in the devices were collected on a PC-based system. Clinical outcomes were office and home BP changes from baseline to end values. RESULTS: Significant reductions in both office BP (-12.9/-6.9 mm Hg, P <.001 and home BP (-6.4/-2.6 mm Hg, P <.01/P <.05) without side effects with 82% responders and good compliance. CONCLUSIONS: Resistant hypertensives can benefit from and are compliant with self-treatment by device-guided slow breathing. 相似文献
5.
6.
The Q Hemostasis Analyzer (Grifols, Barcelona, Spain) is a fully-automated random-access multiparameter analyzer, designed to perform coagulation, chromogenic and immunologic assays. It is equipped with a cap-piercing system. The instrument was evaluated in a hemostasis laboratory of a University Hospital with respect to its technical features in the determination of coagulation i.e. prothrombin time (PT), activated partial thromboplastin time (aPTT), thrombin time, fibrinogen and single coagulation factors V (FV) and VIII (FVIII), chromogenic [antithrombin (AT) and protein C activity] and immunologic assays [von Willebrand factor antigen (vWF:Ag) concentration], using reagents from the analyzer manufacturer. Total precision (evaluated as the coefficient of variation) was below 6% for most parameters both in normal and in pathological ranges, except for FV, FVIII, AT and vWF:Ag both in the normal and pathological samples. No carryover was detected in alternating aPTT measurement in a pool of normal plasma samples and in the same pool spiked with unfractionated heparin (> 1.5 IU/mL). The effective throughput was 154 PT, 66 PT/aPTT, 42 PT/aPTT/fibrinogen, and 38 PT/aPTT/AT per hour, leading to 154 to 114 tests performed per hour, depending of the tested panel. Test results obtained on the Q Hemostasis Analyzer were well correlated with those obtained on the ACL TOP analyzer (Instrumentation Laboratory), with r between 0.862 and 0.989. In conclusion, routine coagulation testing can be performed on the Q Hemostasis Analyzer with satisfactory precision and the same apply to more specialized and specific tests. 相似文献
7.
8.
9.
Gestational diabetes mellitus 总被引:27,自引:0,他引:27
Gestational diabetes mellitus (GDM) is defined as glucose intolerance of various degrees that is first detected during pregnancy. GDM is detected through the screening of pregnant women for clinical risk factors and, among at-risk women, testing for abnormal glucose tolerance that is usually, but not invariably, mild and asymptomatic. GDM appears to result from the same broad spectrum of physiological and genetic abnormalities that characterize diabetes outside of pregnancy. Indeed, women with GDM are at high risk for having or developing diabetes when they are not pregnant. Thus, GDM provides a unique opportunity to study the early pathogenesis of diabetes and to develop interventions to prevent the disease. 相似文献
10.